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ABSTRACT
Histone H1 has seven variants in human somatic
cells and contributes to chromatin compaction and
transcriptional regulation. Knock-down (KD) of each
H1 variant in breast cancer cells results in altered
gene expression and proliferation differently in a vari-
ant specific manner with H1.2 and H1.4 KDs being
most deleterious. Here we show combined depletion
of H1.2 and H1.4 has a strong deleterious effect re-
sulting in a strong interferon (IFN) response, as ev-
idenced by an up-regulation of many IFN-stimulated
genes (ISGs) not seen in individual nor in other com-
binations of H1 variant KDs. Although H1 participates
to repress ISG promoters, IFN activation upon H1.2
and H1.4 KD is mainly generated through the acti-
vation of the IFN response by cytosolic nucleic acid
receptors and IFN synthesis, and without changes
in histone modifications at induced ISG promoters.
H1.2 and H1.4 co-KD also promotes the appearance
of accessibility sites genome wide and, particularly,
at satellites and other repeats. The IFN response may
be triggered by the expression of noncoding RNA
generated from heterochromatic repeats or endoge-
nous retroviruses upon H1 KD. In conclusion, redun-
dant H1-mediated silencing of heterochromatin is im-
portant to maintain cell homeostasis and to avoid an
unspecific IFN response.
INTRODUCTION
There are five major classes of histones that participate in
the correct folding of eukaryotic DNA into chromatin: the
four core histones H2A, H2B, H3 and H4 which form an
octamer that constitutes the nucleosome core particle, and
the linker histone H1, which binds nucleosomes near the
entry/exit sites of linker DNA. Stabilization of the con-
densed states of chromatin is the function most commonly
attributed to linker histone (1), in addition to its inhibitory
effect in vitro on nucleosome mobility (2) and transcrip-
tion (3). Unlike core histones, the H1 histone family is
more evolutionary diverse and many organisms have mul-
tiple variants or subtypes. In humans, histone H1 is a fam-
ily of closely related single-gene encoded proteins, includ-
ing seven somatic subtypes (from H1.1 to H1.5, H1.0 and
H1X), three testis-specific variants (H1t, H1T2 andHILS1)
and one restricted to oocytes (H1oo) (4–6). Among the so-
matic histone H1 variants, H1.1 to H1.5 are expressed in
a replication-dependent manner, while H1.0 and H1X are
replication-independent. H1.2 to H1.5 and H1X are ubiq-
uitously expressed, H1.1 is restricted to certain tissues, and
H1.0 accumulates in terminally differentiated cells.
One of the major open questions in the field is whether
different somatic H1 subtypes are mainly redundant or
have specific functions, functions that are perhaps cell type
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specific. It is well established that H1 subtype composi-
tion varies through development and differentiation as well
as between cell types and during disease associated pro-
cesses such as neoplastic transformation (7–15). H1 sub-
types are post-translationally modified, both at conserved
and unique residues, and these modifications maymodulate
their interaction with an increasing number of proteins at
the nucleoplasm or in chromatin (16,17). These interactions
could explain some reported specific functions for certain
H1 variants (18–23). Furthermore, genomic distribution of
H1 variants is not absolutely redundant, with enrichment
of different variants at certain chromatin types (reviewed in
(6)).We have previously investigated the distribution of four
H1 variants genome-wide in breast cancer cells, conclud-
ing that H1 variants are not distributed uniformly along
the genome, H1.2 being the one showing the most specific
pattern and strongest correlation with low gene expression
(24,25).
Previous studies on the effect of H1 depletion on global
gene expression have found no effect on the vast majority of
genes, but rather have detected variant specific up- or down-
regulation of small subsets of genes (26–29). However, it is
not clear whether these effects are driven by variant specific
roles to regulate particular promoters or play distinct roles
depending on the cell type. For example, H1.2 has been re-
ported to act as a coactivator by bridging between RNA
polymerase II and components of the elongation appara-
tus in 293T cells, and to act as a corepressor by establishing
a positive feedback loop with EZH2-mediated H3K27me3
deposition in MCF7 cells (30,31). Other H1 variants have
been involved in chromatin compaction or gene silencing,
such as H1.4 (21,22,32,33). In general, silent genes contain
histone H1 at the promoter, and a ‘H1 valley’ appears up-
stream of transcription start site (TSS) upon gene activation
(25,34,35).
Altering the expression of H1 variants has been proven
useful to study the contribution of individual variants to nu-
clear processes and to investigate the effects of globalH1 de-
crease. Inmice, single or doubleH1 variant knock-outs have
no apparent phenotype due to compensatory up-regulation
of other subtypes (36). These reports have favored the view
that H1 variants are redundant. Knocking-out additional
subtypes cannot be fully compensated by up-regulation of
the remaining subtypes, resulting in embryonic lethality
and demonstrating that the total amount of H1 is crucial
for proper embryonic development (37). Despite embryonic
lethality, triple knock-out H1.2–H1.3–H1.4 (TKO) mouse
embryonic stem (ES) cells were obtained with a 50% global
reduction in total H1 (27). Among the observed effects of
TKO, a subset of imprinted genes are up-regulated that cor-
respond to specific CpG regions becoming demethylated.
Yang et al. demonstrated that some H1 subtypes specifi-
cally interact with the DNA methyltransferases DNMT1
and DNMT3B to promote methylation of imprinted genes
(38). Major satellite repeats are also de-repressed in TKO
(39). More recently, changes in the epigenetic signature of
thousands of potential regulatory sites across the genome of
TKO ES cells have been described, clustered to gene-dense
topologically associating domains (TADs) (40).
We have previously reported that depletion of single H1
subtypes by inducible RNA interference in cancer cells
produced a range of phenotypic effects, suggesting non-
redundant functions for some of the histone H1 variants
in somatic cells (26). Here, we further investigate conse-
quences of depleting H1 variants by simultaneous deple-
tion of several variants in breast cancer cells. We gener-
ate two new short-hairpin-RNAs (shRNAs), one for the
specific depletion of H1.4, and the other affecting the ex-
pression of several H1 genes (multiH1sh), but mainly H1.2
and H1.4 at the protein level. While H1.2 and H1.4 single
knock-downs (KDs) decrease proliferation similarly, mul-
tiple H1 KD has drastic consequences on cell growth and
induces a strong transcriptional interferon (IFN) response.
We observed the activation of IFN signaling transducers,
participation of cytosolic nucleic acids receptors, IFN syn-
thesis and up-regulation of IFN-stimulated genes (ISGs). In
parallel, satellites and endogenous retroviruses are also up-
regulated and cytosolic RNA is increased. This is the first
report of multiple H1 depletion in human cancer cells, and
we show the importance of histone H1 to maintain hete-
rochromatin integrity and to avoid a growth-inhibiting IFN
response. We also show that pancreatic carcinomas char-
acterized by a constitutively induced IFN response express
low levels of several H1 variants.
MATERIALS AND METHODS
Cell lines, culturing conditions and treatments
Breast cancer T47D-MTVL cells (carrying one stably in-
tegrated copy of luciferase reporter gene driven by the
MMTV promoter) or derivative cells, were grown at 37◦C
with 5% CO2 in RPMI 1640 medium, supplemented with
10% FBS, 2 mM L-glutamine, 100 U/ml penicillin, and
100 g/ml streptomycin, as described previously (26).
HeLa cell line was grown at 37◦C with 5% CO2 in
DMEM GlutaMax medium containing 10% FBS and
1% penicillin/streptomycin. MCF7 cell line was grown at
37◦C with 5% CO2 in MEM medium containing 10%
FBS, 1% penicillin/streptomycin, 1% non-essential amino
acids, 1% sodium pyruvate and 1% glutamine. Doxycycline
(Sigma) was added at 2.5g/ml. IFNß (Sigma), Ruxolitinib
(Selleckchem), BX795 (Selleckchem) and 2-aminopurine
(Sigma) were added at indicated concentrations.
Drug-inducible and constitutive RNA interference
Inducible H1 knock-down cell lines were established from
T47D-MTVL cells as described previously (26). Plasmids
for the lentivirus vector-mediated drug-inducible RNA in-
terference system (pLVTHM, ptTR-KRAB-Red, pCMC-
R8.91 and pVSVG) were provided by Didier Trono (Uni-
versity of Geneva) (41). The 71-mer oligonucleotides for
shRNA cloning into Mlu/ClaI-digested pLVTHM were
designed, annealed and phosphorylated as recommended
by Didier Trono (http://tronolab.epfl.ch/). Target sequences
are GTCCGAGCTCATTACTAAA for H1–4sh and GA
ACAACAGCCGCATCAAG for multiH1sh. For the pro-
duction of viral particles containing the lentiviral vec-
tor and infections, see Sancho et al. (26). The inducible
knocked-down cell lines were sorted in a FACSCalibur ma-
chine (Becton Dickinson) for RedFP-positive and GFP-
positive fluorescence after 3 days of doxycycline (Dox) treat-
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ment. For the constitutive depletion of TLR3, STING,
MAVS, MDA5 and IFNAR, shRNA-expressing pLKO.1
vectors from the MISSION library (Sigma-Aldrich) were
used. Viral particles production and infections were per-
formed as described (26). Cells infected with the shRNA-
expressing lentivirus were selected with 2 mg/ml puromycin
(Sigma-Aldrich) 24 h after infection.
Stable expression of HA-tagged H1 variants
Generation of T47D derivative cells stably expressing HA-
tagged H1 variants using the lentiviral expression vector
pEV833.GFP provided by Eric Verdin (Gladstone Insti-
tutes) was achieved as described previously (26).
RNA extraction and reverse transcriptase (RT)-qPCR
Total RNA was extracted using the High Pure RNA Isola-
tion Kit (Roche). Then, cDNA was generated from 100 ng
of RNA using the Superscript First Strand Synthesis Sys-
tem (Invitrogen). Gene products were analyzed by qPCR,
using SYBR Green Master Mix (Invitrogen) and specific
oligonucleotides in aRoche 480 Light Cyclermachine. Each
value was corrected by human GAPDH and represented
as relative units. Each experiment was performed in dupli-
cate. Specific qPCR oligonucleotide sequences are available
as Supplementary Table S1.
Histone and total protein extraction, gel electrophoresis and
immunoblotting
Histone H1 was purified by lysis with 5% perchloric acid for
1 h at 4◦C. Soluble acid proteins were precipitated with 30%
trichloroacetic acid overnight at 4◦C, washed twice with 0.5
ml of acetone and reconstituted in water. For isolation of
total histones, cell pellets were resuspended in 1 ml of hypo-
tonic solution [10 mM Tris–HCl (pH 8.0), 1 mM KCl, 1.5
mM MgCl2, 1 mM PMSF, 1 mM DTT] and incubated on
ice for 30 min. The nuclei were pelleted at 10 000 × g for
10 min at 4◦C. Sulfuric acid (0.2 M) was added to the pel-
let to extract the histones on ice for 30 min. The solution
was centrifuged at 16 000 × g for 10 min at 4◦C. TCA was
added to the supernatant in order to precipitate histones
and the precipitate was washed with acetone and finally re-
suspended in water. For isolation of total protein, cells were
resuspended with Lysis Buffer [25 mM Tris-H–Cl (pH 7.5),
1% SDS, 1mMEDTA (pH 8), 1 mMEGTA (pH 8), 20 mM
B-glycerolphosphate] containing protease and phosphatase
inhibitors, and boiled 20 min at 95◦C. Cell lysates were ob-
tained by centrifugation and protein concentration was de-
termined by Micro BCA protein assay (Pierce). Purified hi-
stones or cell lysates were exposed to SDS-PAGE (12%),
transferred to a PVDF membrane, blocked with Odyssey
blocking buffer (LI-COR Biosciences) for 1 h, and incu-
bated with primary antibodies overnight at 4◦C and with
secondary antibodies conjugated to fluorescence (IRDye
680 goat anti-rabbit IgG, Li-Cor) for 1 h at room tempera-
ture. Bands were visualized in an Odyssey Infrared Imaging
System (Li-Cor). Polyclonal antibodies specifically recog-
nizing humanH1 variants, including those generated in our
laboratory (26), are available from Abcam: H1.0 (ab11079),
H1.2 (ab17677), H1.3 (ab24174), H1-T146p (ab3596), H1.5
(ab24175) and antiH1X (ab31972). Other antibodies used
were:H1AE-4 (Millipore, 05-457), beta-tubulin (Sigma, no.
T4026), H3K4me3 (Abcam, ab8580), H3K9me3 (Abcam,
ab8898), H3K27me3 (Millipore, 07-449), H4K20me3 (Ab-
cam, ab9053), HP1 (Active Motif, 39295). H1-T146p was
used to identify H1.4 by immunoblot, as the immunogen
was a synthetic peptide derived from within residues 100–
200 of human H1.4, phosphorylated at T146; this antibody
could also recognize phospho T146 in H1.2, H1.3 (both
88% sequence identity with immunogen). To our knowledge
this is the best available antibody to detect loss of H1.4 de-
spite targeting a uniquely phosphorylated residue. To quan-
tifyH1 depletionwithCoomassie staining, we load different
amounts of total histones and choose the ones that showed
the best linear range. After scanning with Image Gauge, in-
dividual histone H1 and H4 bands were quantified and H1
was expressed relative to H4, and relative to untreated cells.
These were approximate quantifications due to the limita-
tions of Coomassie staining of histone preps.
Immunofluorescence
One milliliter of hypotonic MAC buffer [50 mM glycerol,
5 mM KCl, 10 mM NaCl, 0.8 mM CaCl2 and 10 mM su-
crose] was added to 0.5 million cells (resuspended in 1 ml
RPMI 1640 medium) and incubated at room temperature
for 5 min. 400 l were spun down for 10 min at 500 rpm
in a TermoShandon Cytospin 4 using a single-chamber Cy-
tospin funnel as described in (42). Cells were air-dried for 1h
at room tempearature. Then, fixed with 4% paraformalde-
hyde for 1h at room temperature. After three washes, they
were permeabilized with 0.2% Triton X-100 for 15 min at
room temperature and blocked with 3% bovine serum albu-
min for 1 h at room temperature. Then, the cells were incu-
bated with primary antibody recognizing dsRNA (Scicons
J2, English and Scientific Consulting Kft, Hungry) diluted
in the blocking buffer, over-night at 4◦C. After the perti-
nent washes, the secondary antibody Alexa Fluor 488 don-
key anti-mouse (Life Technologies, A21202) was added for
1 h at room temperature in darkness. Nuclei were stained
with DAPI, coverslips mounted usingMowiol, and samples
were visualized by confocal laser scanning microscopy us-
ing a Leica TCS SP5 system.
Cell proliferation analysis
Cells of interest expressing an shRNA (GFP-positive) were
mixed 1:1 with parental cells (GFP-negative) and cultured.
Every three days, the cells were split and the percentage of
cells that were GFP-positive was measured by FACS.
MNase digestion
Cells treated or not with Dox for six days were collected, re-
suspended and incubated for 10 min at 4◦C in Buffer A [10
mM Tris–HCl pH7.4, 10 mM NaCl, 3 mM MgCl2, 0.3 M
Sacarosa and 0.2 mM PMSF], after that 0.2% of NP40 was
added and incubated 10 min more at 4◦C. After centrifuga-
tion, pellets were resuspended in Buffer A + 10 mM CaCl2
and 0.4 u of MNase per 5 millions of nuclei and incubated
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at 37◦C. At different incubation times, MNase reaction was
stopped by adding 10 mM EDTA pH 8. DNA was purified
using EZNA Tissue DNA columns (OMEGA VWR) and
run on a 2% agarose gel.
Chromatin immunoprecipitation (ChIP)
Immunoprecipitation of chromatin was performed accord-
ing to the Upstate (Millipore) standard protocol. Briefly,
cells were fixed using 1% formaldehyde for 10 min at 37◦C,
harvested and sonicated to generate chromatin fragments
of 200–500 bp. Then, 30 g of sheared chromatin was im-
munoprecipitated overnight with 2 g of antibody. Im-
munocomplexes were recovered using 20 l of protein A
magnetic beads, washed and eluted. Cross-linking was re-
versed at 65◦C overnight and immunoprecipitated DNA
was recovered using the PCR Purification Kit from Qia-
gen.Genomic regions of interest were identified by real-time
PCR (qPCR) using SYBR Green Master Mix (Invitrogen)
and specific oligonucleotides in a Roche 480 Light Cycler
machine. Each value was corrected by the corresponding in-
put chromatin sample. Oligonucleotide sequences used for
the amplifications are available on request.
mRNA library preparation and sequencing (RNAseq)
The library from total RNA was prepared using the
TruSeq®Stranded Total Sample Preparation kit (Illumina
Inc.) according to manufacturer’s protocol. Briefly, rRNA
was depleted from 0.5 ug of total RNA using the Ribo-Zero
Gold Kit followed by fragmentation by divalent cations at
elevated temperature resulting into fragments of 80–450nt,
with the major peak at 160nt. First strand cDNA synthe-
sis by random hexamers and reverse transcriptase was fol-
lowed by the second strand cDNA synthesis, performed in
the presence of dUTP instead of dTTP. Blunt-ended dou-
ble stranded cDNA was 3′adenylated and the 3′-‘T’ nu-
cleotide at the Illumina indexed adapters was used for the
adapter ligation. The ligation product was amplifiedwith 15
cycles of PCR. Each library was sequenced using TruSeq
SBS Kit v3-HS, in paired end mode with the read length
2 × 76 bp. We generated minimally 37 million paired end
reads for each sample run in a fraction of a sequencing lane
on HiSeq2000 (Illumina, Inc) following the manufacturer’s
protocol. Images analysis, base calling and quality scoring
of the run were processed using the manufacturer’s software
Real Time Analysis (RTA 1.13.48) and followed by genera-
tion of FASTQ sequence files by CASAVA.
RNAseq data analysis
The mapping of the reads against the human reference
genome (GRCh38) was done using the STARprogram (ver-
sion 2.5.1b) (43) and the quantification of genes was done
with the RSEM program (version 1.2.28) (44). Differen-
tial expression analysis was done with DESeq2 (version
1.10.1) (45). Heatmaps, correlation scatter plot and box-
plots were done using in-house R scripts. The expression
values are those generated by DESeq2 using variance sta-
bilizaing transformations. Genes differentially expressed by
IFN treatment were selected from Interferome database
(version 2.01) (46) applying a filter of 2 < fold-change <
–2 and those differentially expressed in more than one ex-
periment. Enrichment of transcription factor bindingDNA
motifs was done using Homer software (47). Gene ontol-
ogy enrichment analysis was performed using the R pack-
age ‘goseq’ (version 1.18.0) (48) and reduced by semantic
similarity using REViGO software (49). Pathway enrich-
ment analysis and figures were generated using Reactome-
FIPlugin (50) for Cytoscape (51). To perform the enrich-
ment analysis of repetitive sequences the RNA-seq reads
were mapped to the Repbase database (version 21.02) (52)
using Bowtie aligner (default parameters) (53). We only
considered those reads which both paired-end reads were
aligned to the same repetitive sequence. To test for signifi-
cance a Fisher exact test was performed. Significantly en-
riched repetitive sequence were those with a adjusted P-
value < 0,05 and not enriched in RDsh samples.
Assay for transposase-accessible chromatin with high-
throughput sequencing (ATAC-seq)
ATAC experiment was performed as described (54). 75 000
cells treated were harvested and treated with transposase
Tn5 (Nextera DNA Library Preparation Kit, Illumina).
DNA was purified using MinElute PCR Purification Kit
(Qiagen). All samples were then amplified by PCR using
NEBNextHigh-Fidelity 2× PCR Master Mix (New Eng-
lands Labs.) and primers containing a barcode to generate
the libraries. DNA was again purified using MinElute PCR
PurificationKit and samples were sequenced using Illumina
HiSeq 2500 system. Paired-end reads were first trimmed to
30 bp to remove adapter sequences. Then, aligned to the
reference genome (hg19) using bowtie software (53). Dupli-
cated reads and those mapping to the mitochondrial chro-
mosome were removed. Accessibility peaks were obtained
usingMACS2 peak caller software (55). Average accessibil-
ity profile around the TSS of selected genes and pie charts
representing the annotation of peaks was performed using
CEAS software (56). For the repeats accessibility analy-
sis, annotated repeats were taken from the RepeatMasker
track from the UCSC and the number of peaks overlapping
them computed. For the analysis of peaks overlapping up-
or down-regulated genes at the coding regions or promoter,
or repeats, a permutation test (104 permutations) was per-
formed using the R package regioneR (57).
Expression data accession numbers
RNAseq data is available in the Gene Expression Omnibus
(GEO) database under the accession number GSE83277.
Microarray data accession numbers are GSE11294
and GSE12299. ATACseq data accession number is
GSE100762.
Human H1 variant nomenclature
The correspondence of the nomenclature of the human H1
variants with their gene names is as follows: H1.0, H1F0;
H1.1, HIST1H1A; H1.2, HIST1H1C; H1.3, HIST1H1D;
H1.4, HIST1H1E; H1.5, HIST1H1B; and H1X, H1FX.
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RESULTS
Simultaneous depletion of multiple H1 variants in breast can-
cer cells impairs cell growth drastically
We have previously reported the effects of the inducible de-
pletion of six somatic histone H1 variants on cell growth
and gene expression in breast cancer cells (24,26). H1.2 de-
pletion caused cell-cycle arrest in G1 phase, while H1.4 KD
caused cell death in T47D cells. Each variant KD altered
the expression of small distinct subsets of genes.
We have designed and assayed new shRNAs targeting
H1. One of such shRNAs (sh120; H1.4sh) was specific
for H1.4 (Figure 1A and B), while another (sh225; mul-
tiH1 or mH1sh from now on) reduced the expression of
several H1 transcripts, although only H1.2 and H1.4 pro-
teins were seen depleted consistently when tested by im-
munoblotting after 6 days of Doxycycline induced shRNA
expression (Figure 1A and C, and Supplementary Figure
S1). H1.3 was also seen partially depleted in some exper-
iments. The two new shRNAs caused H1.0 up-regulation,
both at the mRNA and protein level. This was previously
observed for H1.2 KD, but not for the other H1 variants
(26). Coomassie staining of histones extracted from mul-
tiH1 KD cells showed that the total content of H1 was re-
duced to ca. 70% despite of H1.0 up-regulation (Figure 1C
andD). The intensity of protein bands containing H1.2 and
H1.4 were decreased.
In addition,multiH1sh expression caused a significant re-
duction in global nucleosome spacing as assessed byMicro-
coccal nuclease digestion of bulk chromatin (Figure 1E and
Supplementary Figure S2). This was almost undetectable
upon H1.4 KD, but was previously described for H1.2 de-
pletion in breast cancer cells (26).
Expression of both shRNAs impaired cell proliferation
(Figure 1F). The effect of inhibiting simultaneously H1.2
and H1.4 in multiH1 KD cells on the growth rate was ad-
ditive compared to single H1 depletion. H1 depletion in-
creased the number of cells in G1 phase of the cell cycle and
reduced cells in S phase, with the effects of multiH1sh being
more pronounced than H1.4sh (data not shown).
Transcriptome changes upon histone H1 variants knock-
down
We studied the consequences on global gene expression of
multiple H1 KD and H1.4-specific depletion compared to
the random shRNA using RNAseq. Data confirmed the ef-
ficacy of H1.4 and multiH1 shRNAs to inhibit the corre-
spondingH1 geneswithout significant compensations other
than some H1.0 up-regulation (Figure 2A). Results were
compared with microarray data obtained before with the
KD of the other variants (24,26). As previously described,
depletion of individual H1 variants altered the expression
of small subsets of genes, considerably specific for each vari-
ant, and containing both up- and down-regulated genes in
different proportions. The inhibition of multiple H1s af-
fected a larger number of genes, some already observed in
single variant KDs (Figure 2B and Supplementary Table
S2). In particular, 38% of genes affected in H1.4sh were also
affected in multiH1sh (which also targets H1.4), while only
20–28%of the genes affected in the other single variantKDs
(H1.0, H1.2, H1.3 or H1.5) were significantly affected in the
multiH1 KD.
Among genes up-regulated in the multiH1 KD, there
were many interferon-stimulated genes (ISGs) (Figure 2C).
Comparison of our data with the Interferome database con-
taining microarray data of IFN-treated cells, showed that
36% of the up-regulated and 18% of the down-regulated
genes in the multiH1 KD were known to also respond to
short- or long-term INF treatments. This is in comparison
to the 6% of the total transcriptome known to be suscep-
tible to IFN treatment (Figure 2C). Almost all the mul-
tiH1 KD up-regulated genes with the highest fold-change
are ISGs. Moreover, fold-change gene induction upon mul-
tiH1 depletion was proportional (positive correlation) to
the fold-change induction in response to IFN in multiple
experiments deposited in the Interferome database (Figure
2D).
Motif analysis in the promoters ofmultiH1sh deregulated
genes found significant enrichment of interferon-stimulated
response elements (ISRE), binding sites for interferon-
responsive transcription factors (IRFs), but not in gamma-
activated sites (GAS) (Figure 2E). ISRE are found in type
I IFN-responsive genes, while GAS elements are present in
type II IFN-stimulated genes. Down-regulated genes con-
tained motifs for E2F, Sp1 and NFY transcription factors
(q-value<0.0001). Gene-ontology analysis confirmed the
enrichment of IFN signaling pathways in themultiH1sh up-
regulated genes, while multiH1sh and single H1.4sh down-
regulated genes showed GO-terms related to cell-cycle reg-
ulation (Figure 2F). No significantly enriched DNA motifs
were found in the promoters of H1.4sh affected genes, and
noGO-terms were found for theH1.4sh up-regulated genes.
Interestingly, basal gene expression (without doxycy-
cline) of genes up-regulated inH1KD cells was significantly
lower than basal expression of genes down-regulated, de-
spite of the variability within each gene set (Figure 2G). Af-
ter H1 depletion, overall gene expression of up- and down-
regulated genes was more similar. This observation could
suggest that histone H1 may play a role in the maintenance
of repression in the up-regulated genes. Nevertheless, both
up- and down-regulated genes showed an average gene ex-
pression above the average of RefSeq genes or even above
the expressed transcriptome (Supplementary Figure S7A).
In conclusion, depletion of individual H1 variants effects
a small subset of genes, while multiple variant knock-down
alters gene expression extensively, larger than the additive
effect of individual variants, including an unexpected large
proportion of type I interferon-stimulated genes. The fact
that there is limited overlap between deregulated genes in
H1.2 or H1.4 KDs and multiH1 KD suggests that these
genes are not directly regulated by these variants, but the
combined depletion of the two variants may trigger an in-
terferon response.
Induction of interferon-stimulated genes upon combined de-
pletion of histone H1 variants
We next sought to understand how the interferon response
is induced in H1-depleted breast cancer cells. Either H1 is
particularly involved in repressing the promoters of ISGs
with little variant specificity, or general H1 depletion from
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Figure 1. Inducible shRNAs for the depletion of histone H1 variants in human breast cancer cells. (A) Expression of H1 variants upon inducible expression
of new shRNAs. T47D derivative cells stably infected with inducible lentiviruses for the expression of random, H1.4 or multi-H1 shRNAs were treated or
not for 6 days with doxycycline (Dox), RNAwas extracted and gene expression was analyzed byRT-qPCRwith oligonucleotides for the indicatedH1 genes.
Gene expression in response to Dox is expressed corrected by GAPDH and relative to untreated cells. Values represent the mean and SD of a representative
experiment performed in triplicate. (B and C) H1 depletion was additionally tested by immunoblotting with the H1 variant-specific antibodies indicated.
H1 phospho-T146 antibody was used to detect H1.4 (pH1.4) (see Materials and methods). (B) H1 from random and H1.4 shRNA cells treated or not with
Dox for 6 days were acid-extracted. (C) Total histones were extracted from multi-H1 shRNAs cells, run on SDS-PAGE and stained with Coomassie or
immunoblotted. (D) Coomassie-stained histone bands were scanned and quantified. The graph denotes the decrease of total H1 and variations of each
H1-containing band (corrected to histoneH4) uponDox treatment of multiH1KD cells. (E) H1KD causes a reduction in nucleosome spacing. Nuclei from
the KD cells indicated treated or not with Dox for 6 days were treated with MNase and the profile of bulk chromatin was analyzed in gel electrophoresis.
A representative experiment is shown. (F) Effect of H1 depletion on cell proliferation. In order to measure the effect of H1 depletion on cell proliferation,
each of the H1 variant KD cell lines indicated (RFP and GFP-positive) was mixed 1:1 with parental T47D cells (RFP and GFP-negative) and treated
with Dox. Every three days, cells were split and the percentage of double-positive cells was measured by FACS. Data is expressed as ratio of positive (KD)
versus negative (wild-type) cells along time and corresponds to a representative experiment performed in duplicate.
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Figure 2. Transcriptome changes upon histone H1 variants knock-down. (A) H1 variants expression in the random, H1.4 and multiH1 KD cells upon
a 6-day Dox treatment extracted from RNAseq data. Data is shown as Log2 of the fold-change Dox-treated compared to untreated. Significant changes
with P-value < 0.001 are shown with asterisks. (B) Venn diagram showing the number of genes up- or down-regulated in H1.4 and multiH1 KD cells
(and not changing in random shRNA ±Dox samples) established by RNAseq (FC ≥ 1.4, adjusted P-value ≤ 0.05). (C) Genes most highly up- (UP) and
down-regulated (DW) in H1.4 and multiH1 KD cells (70 genes of each are shown), not changing in RDsh samples, ordered according to fold-change from
top to down. Genes that respond to IFN according to the Interferome data base (in more than one experiment, with FC ≥ 2) are labeled with asterisks: *,
0.5–3 h IFN-treatment; **, 3–6 h IFN; ***, 6–96h IFN. The table below shows the percentage of genes up- or down-regulated in each H1 KD (FC ≥ 1.4,
adjustedP-value≤ 0.05), or in the total transcriptome, that respond to IFN. (D) Correlation scatter plot between gene expression fold-change in multiH1sh
cells upon Dox-treatment (RNAseq data, FC ≥ 1.4) and fold change upon IFN treatment (Interferome data base, FC ≥ 2). R is the Pearson’s correlation
coefficient, withP-value< 0.0001. Insert table: Number of genes deregulated in multiH1sh that are up- or down-regulated in response to IFN. (E) Enriched
transcription factor binding DNAmotifs in multiH1sh up-regulated genes. (F) Analysis of enriched gene-ontology terms in H1 KD deregulated genes. GO
terms (biological processes) were collapsed by semantic similarity using REVIGO software and the four more significant terms are shown. Enrichment
score is shown as adjusted P-value. (G) Box plots showing the expression profiles of genes up- and down-regulated in H1.4 and multiH1 KD cells, treated
or not with Dox. Significance was tested using the Kolmogorov–Smirnov test (*P-value < 0.05).
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the genome somehow triggers the response by promoting
IFN synthesis. First, we confirmed by reverse transcription
and semi-quantitative PCR (RT-qPCR) the induction of
several ISGs in multiH1sh but not control random shRNA
(RDsh) cells upon 6-days of doxycycline treatment (Figure
3A). Some of the ISGs showed inductions as high as 100-
to 300-fold. A 3-days time curve treatment with doxycy-
cline showed that H1 transcripts, mainly H1.2 and H1.4,
were significantly depleted after 12 h (Figure 3B). ISG up-
regulation was first observed 48 h after treatment start and
was increased at 72 h, both for genes highly induced (IFI27,
IFIT2 and IFI6) or less induced (STAT1, IRF1 and IRF7).
Interestingly, the gene encoding for IFN-ß (IFNB), which
was not found up-regulated in theRNAseq data after 6 days
treatment, was induced at early time points (Figure 3B). In
a longer H1 KD time curve, ISG expression was progres-
sively increased up to 9 or 12 days of doxycycline treatment
(Figure 3C and Supplementary Figure S3). Instead, IFNB,
after peaking at 3 days, decreased its expression, explaining
why it was not detected in theRNAseq experiment (data not
shown). In the same experiment, upon removal of doxycy-
cline at day 3, recovery of H1 variants transcript accumula-
tion was not observed at day 6 but it was at day 9. Upon H1
expression recovery, ISGs were efficiently down-regulated
to basal level, indicating that the IFN response induction
can be reversed upon H1 recovery.
Induction of ISGs was not observed in single H1 KDs,
neither in genome-wide data (microarrays and RNAseq),
nor by RT-qPCR. Figure 3D shows the absence of ISGs in-
duction inH1.2KD constructed in T47D,MCF7 andHeLa
cell lines. In contrast, when the H1.2 inducible shRNA
was introduced into T47D H1.4 KD cells, to obtain a new
multiH1 KD cell line (H1.4/H1.2sh; 80–90% of total H1),
ISGs were highly induced upon doxycycline treatment (Fig-
ure 3E and Supplementary Figure S4). This indicates that
the combined depletion of H1.2 and H1.4 in T47D with
variant-specific shRNAs is sufficient to promote the IFN
response and validates results obtained with the multiH1sh
construct. Induction of ISGs was not unique to T47D cells
as it was also observed in MCF7 infected with the mul-
tiH1sh, whereH1.2 andH1.4 are depleted (data not shown).
We also tested whether other H1 KD combinations
were able to reproduce this effect. The H1.5 inducible
shRNA was introduced into T47D H1.2 or H1.4 KD cells
and all Dox-induced H1 depletions tested by RT-qPCR,
Coomassie and immunoblot. Total H1 content was reduced
to 60–80% of wild-type (Supplementary Figure S5). Si-
multaneous depletion of H1.2 and H1.5 caused ISG up-
regulation to some extent (Figure 3F). Nonetheless, fold-
change induction of ISGs was much higher in H1.4/H1.2sh
than in H1.2/H1.5sh cells (Figure 3E versus F). No ISG
up-regulation was observed upon combined depletion of
H1.4 and H1.5, suggesting that H1.2 depletion is crucial,
although not sufficient, to induce the IFN response. In-
terestingly, the total amount of histone H1 depleted in
H1.4/H1.5sh or H1.2/H1.5sh cells was not lower than the
achieved with the other KD combinations (multiH1sh or
H1.4/H1.2sh), indicating that the induction of the IFN
response is variant specific and not likely due to total
H1 reduction. Finally, H1.4/H1.5sh and H1.2/H1.5sh cells
were further infected with the H1.3 inducible shRNA.
While ISGs remained unaltered in H1.4/H1.5/H1.3sh cells,
they were further induced in H1.2/H1.5/H1.3sh cells, still
to lesser levels than H1.4/H1.2sh (Supplementary Figure
S5C).
To test whether ISGs induction in multiH1sh cells could
be complemented by overexpressing distinct H1 variants,
we infected multiH1sh cells with lentiviruses expressing
GFP and hemaglutinin peptide (HA)-tagged H1.2, H1.3 or
H1.4. Efficient infection was confirmed by FACS analysis
of GFP (80–90% infection) as well as RT-qPCR of H1 ex-
pression (Figure 3F). Although the recombinant H1 genes
were sensitive to the multiH1 shRNA and expression of
HA-tagged H1s was diminished upon Dox treatment, some
expression remained above the levels found in parental mul-
tiH1sh cells, sufficient to observe partial complementation
of the effect of multiH1KD on ISGs induction (Figure 3F).
Immunoblotting confirmed that HA-tagged H1s were still
present after Dox treatment (Supplementary Figure S6). It
is noteworthy that not only H1.2 or H1.4 overexpression
partially complemented the multiH1 KD, but also H1.3, in-
dicating that the IFN response induction by H1 depletion
is not fully variant-specific.
Synthesis of interferon and induction of IFN signaling upon
multiple H1 depletion
Together these data suggest that H1 depletion mimics or
induces the IFN response, for example inducing IFN pro-
duction. The IFN response is triggered in cells when for-
eignDNAorRNAs are recognized by cytosolic nucleic acid
sensors that trigger a signaling cascade, leading to the acti-
vation and nuclear entry of IFN-responsive transcription
factors (IRFs). These IRFs then bind and regulate the pro-
moter of IFN-encoding genes and other ISRE-containing
target genes. IFN is secreted to the media, where it binds
and activates IFN receptors at the surface of responsive
cells, which activate the Janus kinase (JAK)-STAT signaling
pathway leading to further activation of IRFs and ISRE-
containing target genes (by type I IFNs), or to the activa-
tion of genes containing gamma-activated sites (GAS) el-
ements (by type II IFN). IFN stimulation classically re-
sults in an anti-viral immune response and also has anti-
tumor effects inducing ISGswith anti-proliferative and pro-
apoptotic functions (58,59).
Induction of ISGs upon H1 depletion could be mediated
by IFN synthesis, because, as reported above, the IFNB
gene (but not IFNA) was up-regulated at short times af-
ter Dox addition to multiH1sh cells (Figure 3B). First, we
confirmed that T47D derivative cells were sensitive to com-
mercial IFN-ß, and induction of ISGs by IFN-ß at 0.15
g/ml was comparable to the upregulation achieved by
the combined KD of H1.4 and H1.2 (Figure 4A). ISG
induction was not increased by higher concentrations of
IFN-ß (1.2 g/ml), but was synergistic with the effect of
H1.4/H1.2 KD (Dox treatment), suggesting that ISG in-
duction by H1 depletion is not only due to IFN synthe-
sis. The effect of IFN-ß was not potentiated by knocking-
down individuallyH1.2 orH1.4 (Figure 4A).We then tested
whether IFN was being produced and liberated to the ex-
tracellular media. Conditioned growth media of multiH1
KD cells treated with Dox for 3 days was added to wild-
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Figure 3. Induction of interferon-stimulated genes upon combined depletion of histone H1 variants. (A) Induction of ISGs in multiH1 KD cells. T47D
cells containing RDsh or multiH1sh were treated or not with Dox for 6 days and gene expression was tested by RT-qPCR with oligonucleotides for the
indicated genes. Gene expression in response to Dox is expressed corrected by GAPDH and relative to untreated cells. (B) ISG and H1 variants expression
along time after Dox treatment. T47D cells containing multiH1sh were treated with Dox up to 72 h and gene expression was tested as in (A). Gene
expression is corrected by GAPDH and relative to the highest data point for each gene. (C) H1 expression recovery and reversal of ISG expression after
Dox removal. MultiH1 KD cells were treated with Dox for 3 days and split, washed and maintained without Dox or left with Dox up to 12 days. Gene
expression was tested by RT-qPCR every 3 days, corrected by GAPDH and shown relative to untreated (time 0). (D) ISG induction occurs in multiH1sh
but not H1.2sh cells. The indicated cell lines containing RDsh, multiH1sh or H1.2sh were treated or not with Dox for 6 days and ISG15 and IFIT1 gene
expression was tested and expressed as in (A). (E) ISGs are induced in a double H1.4/H1.2 KD cell line. T47D cells containing H1.4sh were infected
or not with the H1.2 shRNA-expressing lentivirus. Resulting cells were treated or not with Dox for 6 days and ISG expression was tested as in (A) and
expressed relative to untreated cells. (F) ISG induction in a double H1.2/H1.5 KD cell line. T47D cells containing H1.2sh or H1.4sh were infected with an
H1.5 shRNA-expressing lentivirus. Resulting cells were treated or not with Dox for 6 days and ISG expression was tested as in (A). (G) H1 overexpression
in multiH1 KD cells partially blocks ISG up-regulation. T47D cells containing multiH1sh were infected or not with a lentivirus for the expression of
HA-tagged H1.2, H1.3 or H1.4 variants. Resulting cells were treated or not with Dox for 6 days and H1 variant and ISG gene expression was tested as in
(A). Values represent the mean and SD of representative experiments performed in triplicate.
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Figure 4. Activation of the interferon response pathway upon depletion of histone H1. (A) IFN-ß enhances ISG induction in H1.4/H1.2sh cells. T47D
cells containing H1.2sh, H1.4sh or H1.4/H1.2sh were treated or not with Dox for 6 days and IFN-ß at 0,15 (+) or 1,2 (++) g/ml was added for the last 8
h before analysis of ISG expression, corrected byGAPDH. (B) ISG induction by IFN liberated to the media. T47D cells containingmultiH1sh were treated
with Dox for 3 days, media was collected and added to wild-type T47D cells for 24 h. For comparison, T47D cells were treated with commercial IFN-ß
(0.15 g/ml) for 24 h, and multiH1sh cells treated with Dox for 3 days. ISG expression was tested by RT-qPCR, corrected by GAPDH and expressed
relative to untreated cells. (C) ISG induction is blocked with IFN pathway inhibitors. T47D multiH1sh cells were treated or not with Dox, 0.5 MBX795,
1 M ruxolitinib or 10 mM 2-aminopurine, for 3 days, and ISG expression was tested as in (A). Gene expression is corrected by GAPDH and relative to
the highest data point for each gene. (D) Blocking ISG induction by knocking-down type-I IFN receptor or IFN pathway sensors and transducers. T47D
multiH1sh cells stably expressing shRNAs against IFNAR1, TLR3 (upper panels), STING, MAVS or MDA5 (lower panel) were treated or not with Dox
for 6 days and ISG expression was tested as in (A) compared to parental multiH1sh cells. Gene expression is corrected by GAPDH and represented relative
to untreated cells. Values represent the mean and SD of representative experiments performed in triplicate.
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type T47D cells and ISG expression was tested. The media
was able to stimulate expression of ISGs to some extent,
although to a lesser extent than was achieved by treating
cells with commercial IFN-ß (Figure 4B). Moreover, when
a shRNA against the type I IFN receptor IFNAR1 was in-
troduced into multiH1sh cells, ISG stimulation upon Dox
treatment was partially affected (Figure 4D). In conclusion,
multiH1 depletion has an effect on the induction of ISGs
that is partially explained by the production and reentry of
IFN.
To further determine the involvement of signaling as-
sociated to the IFN response, we analyzed the effect of
inhibitors of kinase TBK-1, an intermediate in the sens-
ing cascade, and Janus kinase (JAK) 1 and 2, BX795 and
Ruxolitinib, respectively. Both inhibitors impaired the up-
regulation of several ISGs (Figure 4C).
DNA and RNA cytosolic sensors trigger the IFN re-
sponse with different specificity. Examples include MDA5
(IFIH1), RIG-I (DDX58), TLRs, cGAS or IFI16. These
receptors activate intermediates such as MAVS (IPS-1) or
STING that activate kinase TBK-1, which activates IRFs.
We introduced shRNAs to deplete MDA5, TLR3, MAVS
and STING from multiH1sh cells and observed a decrease
in ISG stimulation upon Dox treatment (Figure 4D). Im-
portantly, the factor that contributed the most to ISG up-
regulation in multiH1 KD cells was MDA5, an RNA sen-
sor, and the one that did it the least was STING, an adap-
tor of the DNA sensor pathway. Treating multiH1sh cells
with 2-aminopurine, an inhibitor of IFN-inducible dsRNA-
activated protein kinase R (PKR, EIF2AK2), which is in-
volved in sensing dsRNA and activating MAVS, also im-
paired the activation of several ISGs (Figure 4C).
All together, these data show that upon H1 depletion an
IFN response is being induced with participation of cytoso-
lic sensors and signal transducers and features the synthe-
sis of IFN, suggesting that some nucleic acid may be pro-
duced at the cytosol as a consequence of H1 depletion.
Several genes involved in sensing and responding to for-
eign nucleic acids were up-regulated in multiH1 KD cells,
including DDX60, IFI16, MDA5, RIG-I, LGP2, STAT1,
IRF1, IRF7, IRF9, OASL andOAS2. Enrichment pathway
analysis denoted that pathways like ‘RIG-I/MDA5 (RNA
sensing molecules)-mediated induction of IFN-alpha/beta’
were significantly enriched, but not ‘cytosolic sensors of
pathogen-associated DNA’, suggesting that the IFN re-
sponsewas being induced byRNAmolecules uponmultiH1
KD (data not shown).
Induction of repeats and endogenous retroviruses upon his-
tone H1 knock-down
It has been previously reported that DNA methyltrans-
ferase inhibitors (DNMTis) induce the IFN response path-
way in cancer cells with anti-proliferative effects by inducing
synthesis of endogenous dsRNAs from endogenous retro-
viruses, DNA repeats and non-coding transcripts (60–62).
We hypothesized that spurious transcription could be tak-
ing place from non-coding RNA genes, DNA repeats, satel-
lites or endogenous retroviruses (ERVs), which are generally
located in heterochromatin, and are sensed as foreign thus
activating the IFN response.
Expression of several repeats was assessed by RT-qPCR
in T47D multiH1sh cells upon Dox treatment, using ran-
dom shRNA cells as a control (Figure 5). Some repeats
were chosen because were found up-regulated in our mul-
tiH1shRNAseq data (MER4D,HERVKandLTR57) (data
not shown). Others were selected due to its high abundance
of histone H1 variants according to our ChIP-seq data
(MLT1J2) (data not shown, (25)). Expression of the endoge-
nous retroviruses (ERVs) MER4D, MER21C, MLT1C49,
HERVK, Env-Fc1, LTR57, MER25A and MLT1J2, the
subtelomeric repeat D4Z4 and satellite A, are shown to be
up-regulated to different extent upon multiH1 inhibition,
but not in control treatment (Figure 5A). Up-regulation of
these repeats was also observed in H1.4 + H1.2 combined
KD cells, but not as much in individual H1 KDs (Figure
5B). Although some repeats are induced to some extent in
individual H1 KDs, this is insufficient to trigger the IFN
response. Higher induction of a wider number of repeats
achieved with the double KD may be the cause of the IFN
pathway stimulation observed.
To test that expression of ERVs is the origin of IFN sig-
naling activation, we tested whether inhibition of retrotran-
scriptase (RT) activity affected the up-regulation of ISGs in
multiH1 KD cells. MultiH1sh cells were treated for 3 days
with doxycycline and a cocktail of RT inhibitors (Tenofovir
0.5 M, Nevirapine 17 M, Emtricitabine 7.3 M). ISGs
were induced similarly in the presence ofRT inhibitors (data
not shown), indicating that cDNA synthesis is not required
and confirming that RNA could be the triggering molecule.
According to our data, a plausible model on how mul-
tiple H1 KD induces the IFN response would be that H1
depletion from heterochromatin may induce several non-
coding RNAs from endogenous retroviruses, satellite and
other repeats, that are sensed in the cytosol as exogenous
(ds)RNAs. Immunofluorescence with the specific antibody
J2 denoted that dsRNA was accumulated into the cytosol
of multiH1sh cells upon doxycycline treatment (Figure 5C).
Furthermore, analysis of the distribution of RNAseq reads
in multiH1 cells demonstrates that upon H1 inhibition the
proportion of intergenic and intronic reads respect to ex-
onic reads was increased significantly (ca. 16% and 30%,
respectively) (Figure 5D). This suggests that H1 depletion
increases transcriptional noise, which may favor the accu-
mulation of unexpected RNAs.
H1 abundance at genes deregulated by H1 depletion corre-
sponds to its basal expression level
Additionally, H1 could accumulate at the ISG promoters
for repression in the absence of IFN signaling, and severe
H1 depletion could be enough to induce several of those
genes (as reported elsewhere (63)), including IFN-encoding
genes, mimicking an IFN-like response. Using our previ-
ously generated ChIP-seq data on H1 variants distribution
in T47D cells (25), we analyzed H1 abundance at promoter
and coding regions of multiH1sh regulated genes compared
to total genes. Genes up- or down-regulated in multiH1KD
cells are not enriched in any particularH1 variant compared
to the total genes of the genome, although someH1s includ-
ing H1.2 are more abundant in up- than down-regulated
genes, which likely accounts for the fact thatH1.2 is the vari-
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Figure 5. Expression of repetitive DNA upon histone H1 knock-down. (A) T47D cells containing RDsh or multiH1sh were treated or not with Dox for
3 days and expression of several repeats and endogenous retroviruses were tested by RT-qPCR. Expression in response to Dox is expressed corrected by
GAPDH and relative to untreated cells. (B) T47D cells containing H1.2sh, H1.4sh or H1.4/H1.2sh were treated with Dox for 3 days and expression of
repeats was tested and represented as in (A). Values represent the mean and SD of representative experiments performed in duplicate. Significance was
tested using a t-test (*P-value<0.05; **P-value < 0.01). (C) Accumulation of dsRNA in multiH1sh cells. Cells were treated or not with Dox for 6 days
and submitted to immunofluorescence staining of dsRNA using J2 antibody. DAPI was used to stain the nucleus. (D) Relative number of intergenic or
intronic RNAseq reads compared to exonic reads in RDsh or multiH1sh treated or not with Dox. Asterisks mark significance (P < 2e–16) in Dox-treated
compared to untreated.
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ant that better correlates negatively with gene expression
(25), and up-regulated genes present lower basal gene ex-
pression as shown in Figure 2G (Supplementary Figure S7B
and C). Interestingly, genes within the up-regulated gene set
that show the highest responsiveness to IFN according to
the Interferome data base, presented a lower basal gene ex-
pression average and a higher H1 content around the TSS
(data not shown).
H1 variant ChIP-seq signals were similar around TSS of
genes (25) up- and down-regulated genes inmultiH1sh (Fig-
ure 6B and Supplementary Figure S7D). Both sets of genes
showed H1.2 depletion around the TSS. Instead, H1.0 and
H1.4 showed a local enrichment 1-kb at each side of the TSS
of up-regulated genes, while down-regulated genes showed
an average depletion ofH1 around the TSS.Overall, H1was
more abundant in up-regulated genes, although not as high
as in non- or lowly-expressed genes.
Genes highly responsive to multiH1sh and IFN may be
tightly repressed with participation of H1.2 orH1.4 (among
other variants) and, as a consequence, severe H1 depletion
may render these genes open for transcription to take place.
An open question is what makes these genes particular for
being up-regulated upon H1 depletion. We randomly se-
lected a subset of genes that remained repressed upon H1
reduction and analyzed the content of H1.2 in their proxi-
mal promoters. We found that H1 content at up-regulated
genes was not significantly different to genes with low ex-
pression levels (Supplementary Figure S7E) and indeed H1
content most consistently correlated to expression levels in
the absence of doxycycline. In conclusion, an increased H1
content does not seem to be the reason for up-regulation
upon H1 depletion.
Gene activation by H1 depletion occurs without canonical
marks of active chromatin
We next analyzed H1 variant levels at gene promoters by
ChIP-qPCR. We found that H1.2 was present and being
removed equally from up-regulated ISGs and uninduced
(control) genes upon multiH1 KD, as well as from several
DNA repeats and ERVs analyzed (Figure 6A). H1X abun-
dance remained unchanged upon doxycycline treatment,
even at induced genes (ISGs and H1.0). As a control, de-
creased H1s at TSS of active genes (CDK2 and H1.0) com-
pared to an upstream (–3 kb) region, was observed, but not
for a repressed gene (NANOG).
In parallel, we analyzed changes in core histone mod-
ifications related to gene expression and open chromatin
(H3 and H4 pan-acetylation, and H3K4me3), or repres-
sion and closed chromatin (H3K9me3, H3K27me3 and
H4K20me3). In general, active marks were present at ac-
tive genes and absent from repeats, as expected. Repres-
sive marks were more abundant at repeats and NANOG.
Interestingly, H1.0 activation upon multiH1 KD was only
marked by histone acetylation at TSS, but not H3K4me3.
In contrast, all histone marks remained unaltered at TSS of
all the ISGs analyzed that get activated upon multiH1 KD
(Dox treatment) (Figure 6A). This is particularly puzzling
for the canonical transcription initiation-associated mark
H3K4me3. Differences between ISGs existed, but were not
increased with Dox. Repressive marks were also mainly un-
altered, and the same happened within repeats. We have
previously reported that genes strongly up-regulated upon
H1X KD did not present an H1 valley nor H3K4me3 in-
crease at TSS (24), suggesting that gene activation byH1 de-
pletion may occur without canonical marks of active chro-
matin, as recently reported to occur in certain genes (64).
How the ISGs become activated uponH1 depletionwithout
changes in histone marks remains elusive. Activation could
be mediated by recruitment of activated IRFs into ISG pro-
moters where active marks are already constitutive and H1
is depleted. It is noteworthy that in an experiment of treat-
ment with IFN-ß, active marks were also not observed to
be increased (data not shown).
We also analyzed whether these marks were altered glob-
ally by western blot on chromatin extracts. H3K9me3
and H3K27me3 marks were not altered, although HP1
signal was decreased in multiH1 KD cells (Figure 6C).
H1.4 with the K26me3 post-translational modification has
been proposed to bind the heterochromatin protein HP1
(21,32), suggesting H1.4 depletion could have an effect on
chromatin-bound HP1, potentially impacting heterochro-
matin integrity and repeat repression.
Changes in chromatin accessibility upon H1 depletion
We have also analyzed changes in chromatin accessibil-
ity upon multiH1 KD. We assessed chromatin accessibil-
ity by ATAC-seq in T47D multiH1sh upon Dox treatment
compared to untreated. As a control, accessibility at TSS
of genes with unchanged expression was analyzed. Genes
highly expressed showed more accessibility than poorly ex-
pressed genes (Figure 7A). Genes up and down-regulated
in multiH1 KD cells showed slightly different accessibil-
ity levels at TSS, and only up-regulated genes showed in-
creased TSS accessibility upon H1 KD (Figure 7B). Next,
we searched for peaks of increased accessibility in Dox-
treated multiH1sh cells compared to untreated cells within
the genome-wide ATAC-seq data. Then, we calculated
whether up or down-regulated genes presented an increased
number of such newly accessible peaks compared to permu-
tations of randomized genes. Up-regulated genes showed a
tendency to have increased number of accessibility peaks
both at their promoter and coding regions (P-value = 0.17
and 0.06, respectively), in agreement with its increased tran-
scriptional state in multiH1 KD cells. Conversely, down-
regulated genes showed reduced accessibility (P-value =
0.18 and 0.03 for promoter and coding regions, respec-
tively).
Finally, we computed the genomic distribution of accessi-
bility peaks and whether peaks were enriched within some
category of repetitive DNA. Upon H1 depletion, accessi-
bility peaks were enriched within introns and distal inter-
genic regions (Figure 7C), and at satellites, rDNA and sim-
ple repeats (Figure 7D). Among satellites where peaks were
found enriched, we found SATa and SST1 which were up-
regulated uponmultiH1KD (Figure 5A). These results sup-
port the notion that H1 depletion generates regions of open
chromatin, including regions where repeats were repressed,
that might generate synthesis of (ds)RNAs that are sensed
at cytoplasm and induce the IFN signaling response.
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Figure 6. Changes at ISG promoters and chromatin upon H1 depletion. (A) Histone modification changes at promoters upon multiH1 KD. T47D cells
containing multiH1sh were treated or not with Dox for 6 days and chromatin was extracted and immunoprecipitated (ChIP) with the indicated antibodies.
Abundance at specific genomic regions (ISGs, DNA repeats and control genes) was quantified by real-time PCR and expressed relative to input DNA
amplification. Oligonucleotides at the indicated promoters correspond to TSS or -3kb distal promoter (UPS). Values represent the mean and SD of
a representative experiment performed in duplicate. (B) H1.2 abundance at TSS of deregulated genes. Average density profile of H1.2 abundance (input-
subtractedChIP-seq signal) around the TSS of up- or down-regulated genes uponmultiH1KD.RefSeq genes (All), as well as bottom and top 10% expressed
genes (groups 1 and 10 in Supplementary Figure S7A), are shown as reference. (C) Chromatin-bound HP1 is decreased upon multiH1 KD. T47D cells
containing multiH1sh were treated with Dox for 6 days and chromatin was extracted and immunoblotted with the indicated antibodies. Coomassie staining
of core histones is shown.
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Figure 7. Changes on chromatin accessibility upon depletion of histone H1. T47D cells containing multiH1sh were treated or not with Dox for 6 days
and submitted to ATAC-seq. (A and B) Average profiles of accessibility around the center of TSS, normalized to reads depth, for the following groups of
genes: bottom and top 10% expressed genes (groups 1 and 10 in Supplementary Figure S7A) (A), and up- and down-regulated genes in multiH1 KD cells
(B). (C) Genomic annotation of high accessibility regions (narrow peaks) enriched in multiH1sh Dox-treated compared to untreated cells, shown as pie
diagram and table (% of total). For comparison, the genomic annotation of accessibility sites in control cells (untreated) is shown. Asterisks mark genomic
categories enriched in differential mH1sh accessibility peaks compared to control or vice versa (P-value < 0.001). (D) Distribution of high accessibility
peaks enriched in multiH1sh cells among the different annotated categories of genomic DNA repeats. Asterisks mark those repeat categories where the
number of peaks obtained is significantly higher (P-value < 0.001) than expected in randomized samples (104 permutations) mimicking the accessibility
peaks file. Within the satellite category, types that were significantly enriched are shown in the right panel.
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Low expression of replication-dependent H1 variants in pan-
creatic adenocarcinomas over-expressing genes of the IFN
pathway
Seeing a potential link between H1 variant levels and ac-
tivation of the IFN response, we looked for other mod-
els in which this link may be apparent. Resistance to on-
colytic viral therapy in pancreatic adenocarcinomas and
multiple myelomas has been associated with overexpression
of the anti-viral innate immune response (65). Monsurro`
et al. identified two molecular phenotypes of pancreatic
cancer characterized by a differential expression of genes
associated with IFN signaling (66). We have constructed a
cluster dendrogram of the expression of IFN signaling re-
lated genes in pancreatic cancer and normal samples ob-
tained from databases that has defined three groups of sam-
ples, where group 1 contain mainly normal samples and
groups 2 and 3 contain most tumor samples (Supplemen-
tary Figure S8). Groups 2 and 3 show overall up-regulation
of IFN-related genes compared to group 1, while no differ-
ences in expression of randomly chosen genes exist among
groups (Figure 8). Next we plotted the expression of H1
variants in all the samples of the three groups, and observed
that many replication-dependent H1 variants are down-
regulated in sample groups presenting ISGs up-regulation,
while replication-independent variants are up-regulated, re-
sembling the situation in our T47D multiple ‘replication-
dependent’ H1 KD where ISGs are up-regulated.
However, most cancer types show an up-regulation of
H1-encoding genes compared to normal tissue, including
breast carcinoma (10). An interesting reported exception is
the low H1.2 expression in colorectal cancer compared to
normal tissue. ISG expression was not increased in colorec-
tal cancer compared to normal samples despite of the low
H1.2 expression in cancer samples, indicating that the cor-
relation in pancreatic cancer does not extend to colorectal
cancer where onlyH1.2 is down-regulated (data not shown).
This is consistent with our results, wherein we only register
an IFN response in multi-variant down-regulation.
DISCUSSION
This work extends our research on the biological effects
of depleting histone H1 variants in cancer cells, by adding
shRNA-expressing vectors against H1.4 and simultaneous
depletion of several variants with a single shRNA (mul-
tiH1), or combining shRNAs. We reported before that indi-
vidual H1 KDs alter expression of small subsets of genes in
T47D cells, with little overlap between variants. Knocking-
down individual variants affects proliferation to different
degrees. Our experiments show that any H1 variant KD is
unable to completely impair cell growth, whether because
depletion is incomplete or because H1 variants present
some redundancy. Instead, simultaneous depletion of mul-
tiple H1 variants has drastic consequences on cell prolifer-
ation. We have tested different combinations of H1 KDs,
and found co-KD of H1.2 + H1.4 to be the combination
with greatest inhibition of cell growth (data not shown).
Our results suggest that these two variants are most impor-
tant for cell homeostasis. Either the two variants play re-
dundant roles, or the observed consequences of multiH1s
are due to the additive effects of impairing H1.2 and H1.4
non-redundant functions. Because distribution of H1.2 and
H1.4 in the genome is not redundant (25), we favor the sec-
ond explanation.
Nonetheless, the gene expression profile of multiH1 KD
cells is not explained by simple addition of the H1.2 and
H1.4 KD profiles. Combination of gene expression profil-
ing and ChIP-seq data of H1s variants fails to show that
these genes are specifically targeted and directly regulated
by the corresponding variant. Multiple H1 KD present a
considerable number of genes deregulated; roughly, 3-times
the number of the sum of genes deregulated in H1.2 and
H1.4 single KDs. Interestingly, a big proportion of genes,
in particular the strongest up-regulated genes, are related
to the IFN response. It is worth mentioning that genes up-
regulated upon multiH1 KD are genes that are silenced un-
der basal conditions. The opposite is true for the down-
regulated genes. As before, we do not support the hypothesis
that all these ISGs are maintained repressed particularly by
H1.2 and H1.4, as others have suggested (63). Although we
have found that H1s are enriched in the promoter and cod-
ing regions of genes up-regulated in multiH1KD compared
to other genes, we show that thisH1 content is characteristic
of genes presenting that low basal expression rates and do
not represent especially silenced H1 targets. We have shown
before thatH1 content correlates positivelywith gene silenc-
ing in T47D, with H1.2 having the highest degree of corre-
lation (24,25).
We believe ISG induction in multiH1 KDmay be caused
by the production and cytosolic sensing of unusual nu-
cleic acids, and secondarily through the synthesis of IFN.
We show here that several intermediate components of the
IFN signaling pathway are up-regulated upon doxycycline
treatment of multiH1 KD cells, type-I IFN is being ex-
pressed and liberated to the media, and ISG stimulation is
depending on the presence of several pathogen recognition
receptors (MDA5, TLR3) and adaptor molecules (MAVS,
STING), on type-I IFN receptors, and on TBK and JAK
activation.
Several recent reports have shown that DNMT inhibitors
with anti-proliferative effects induce the IFN response path-
way in cancer cells by inducing synthesis of dsRNAs from
endogenous retroviruses, DNA repeats and non-coding
transcripts (60–62). The striking similarity of these reports
with our observations led us to investigate whether mul-
tiH1 depletion was leading to spurious transcription from
non-coding RNA genes, DNA repeats, satellites or endoge-
nous retroviruses (ERVs), generally located in heterochro-
matin. Enrichment pathway analysis of our multiH1 KD
expression data indicated that the IFN response is induced
by RNA transcripts, not by DNA, as only genes belong-
ing to the RNA-sensing pathway are up-regulated. Accord-
ingly, we detected expression of satellite repeats and ERVs
that might be induced upon heterochromatin relaxation.
Fittingly, both variants depleted by our multiH1sh have
been associated with maintaining heterochromatin. First,
H1.4 has been suggested to associate with heterochromatin
through its ability to recruit HP1, L3MBTL1 and poly-
comb proteins through H1.4K26me (21,22,32,33,67,68).
H1.2 may have multiple roles, as it has been associated with
active transcription and repression and in complex with dif-
ferent partners (30,31,69). In T47D cells, we have charac-
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Figure 8. H1 expression in pancreatic normal and cancer samples clustered according to the expression of IFN signaling related genes. Supervised cluster
analysis of IFN related genes in 36 pancreatic tumor and 16 normal samples usingmicroarray data deposited inGSE16515, defined 3 groups of samples (see
Supplementary Figure S8). Box plots represent the expression of IFN related genes andH1 variants, ether individually or grouped as replication dependent
or independent H1s, in the three groups of samples. Expression of a representative set of genes chosen randomly is shown as a control. Significance was
assessed using the Kolmogorov-Smirnov test. Significant difference between groups 2 or 3 and group 1 is marked with asterisks (P < 0.05). Relative
expression units have been omitted for simplicity.
terized H1.2 as enriched within lamin-associated domains
(LADs), intergenic regions, repressed chromatin and gene-
poor chromosomes (25).
We have tried to establish whether derepression of repeats
and induction of the IFN response is due to overall decrease
on the H1 content, or to the specific depletion of H1.2 +
H1.4. Single KD of these variants does not cause these ef-
fects in T47D cells. Other double KD combinations are less
effective (H1.2 + H1.5) or ineffective (H1.4 + H1.5). This
would suggest that H1.2 is important to maintain repres-
sion, but not sufficient alone, and requires H1.4 also partic-
ipating.
An alternate hypothesis is that total H1 content could be
the key determinant of the observed multiH1 KD effects.
Indeed, up-regulation of ISGs in T47D multiH1 KD was
complemented equally by H1.2, H1.3 or H1.4 overexpres-
sion, going against the notion that H1.2 is essential, and fa-
voring redundancy between variants.We reported elsewhere
the approximate content of H1 variants in T47D cells, rep-
resentingH1.2, H1.4 andH1.5, 20–30% of the total H1 con-
tent each (26). Then, assuming complete depletion, H1.2 +
H1.4 inhibition should not represent a decrease on the total
H1 content larger than the inhibitionsH1.2 +H1.5, orH1.4
+ H1.5. In fact, Coomassie staining of histone extracts has
shown that totalH1 contentwas reduced to 70–80%ofwild-
type in multiH1 or H1.4/H1.2 KD cells. H1 content reduc-
tion in the other double KDs (H1.2/H1.5 and H1.4/H1.5)
we generated was comparable (down to 60–80%) despite
of incomplete H1.5 depletion. Furthermore, simultaneous
depletion of H1.3/H1.4/H1.5 rendered ISGs unaltered. In
conclusion, the observed effects are better explained by the
specificity ofH1.2 andH1.4 functions than by the reduction
of overall H1 content.
Because total H1 content and the abundance or distribu-
tion of the different variants may differ between cell types,
KD of single or multiple variants may have different out-
comes within different models. Despite of this, we have de-
tected ISG induction also in MCF7 multiH1 KD cells. In-
terestingly, by analyzing publically available transcriptomic
data, we have detected ISG up-regulation in H1.2 (and
EZH2) KD experiments performed by another group in
MCF7 (31) and 293T cells (30) (data not shown), although
induction of the IFN response was not reported in those
studies. Both data sets show a better overlap with our T47D
multiH1sh up-regulated genes subset than with the H1.2sh
up-regulated genes. This indicates that H1 variant depletion
has different transcriptional effects in different cell types,
and H1.2 depletion is not sufficient to induce the IFN re-
sponse in T47D cells but induces to some extent several
ISGs in HeLa (see below) (63), MCF7 and 293T, further ar-
guing in favor of a special role for H1.2. All together these
studies confirm the notion that H1 depletion may trigger
this innate immune response in several cell types.
Single and double H1 knock-outs (KO) in mice have
limited effects due to compensation and redundancy, but
drastic effects were observed in triple KO (TKO) embryos
and MEFs due to reduction of H1 total content to 50%
(27,36,37). Yang et al. demonstrated that some H1 sub-
types specifically interact with the DNAmethyltransferases
DNMT1 and DNMT3B to promote methylation of im-
printed genes, which become up-regulated in mouse TKO
(27,38). Major satellites are also up-regulated in mouse
TKO (39), and because DNMTis induce the IFN response
pathway in cancer cells by inducing synthesis of DNA re-
peats (60–62), we hypothesized that multiple H1 depletion
in breast cancer cells could lead to DNMTs displacement
and demethylation of heterochromatic repeats leading to
IFN signaling. Then, treatment with DNMTis and H1 de-
pletion would have similar effects. Treatment of T47D cells
with 5-aza-2′-deoxycytidine (aza-dC) for 3 days did not in-
duce the expression of ISGs, but enhanced the effect of mul-
tiH1KD (Supplementary Figure S9). Response of theDNA
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Figure 9. Model of H1 involvement in the repression of the interferon response. Histone H1 participates in the repression of strongly silenced genes such
as ISGs under basal conditions, and in the repression of non-coding transcripts derived from repeats such as satellites, transposons and endogenous retro-
viruses located in heterochromatic regions which may cause, upon induction in H1-depleted cells, activation of the IFN signaling pathway. Transcription
of repeats may give raise to ss/dsRNAs (60–62) or non-B DNA structures such as R-loops (70), that could be sensed by universal (HMGBs) or ligand-
specific cytosolic sentinels (DDX60) that activate RNA (MDA5/IFIH1, RIG-I, LGP2, OASs) or DNA sensors (cGAS, IFI16), or bymembrane-associated
Toll-like receptors (TLRs). These proteins transduce the signal to specific adaptors (MAVS/IPS1, STING), leading to the activation of TBK-IRFs and
IKK-NFkB. These transcription factors bind specific sites at ISG promoters, including genes for the synthesis of type I IFN that upon interaction with
specific receptors lead to the activation of JAK-STAT pathway and additional IRFs. For simplicity, few of the sensor and adaptor proteins are drawn. ISGs
up-regulated in multiH1 KD cells include DDX60, MDA5/IFIH1, RIG-I/DDX58, LGP2, PKR, OAS1/IFI4, OAS2, OASL, IRF1, IRF7, IRF9, IFNB,
STAT1 (in green). HMGB1, HMGB2 and HMGB3 are down-regulated. Inhibitors of members of the IFN signaling pathway are shown (in red).
repeats to aza-dC was heterogeneous (data not shown). So,
in T47D cells, DNMTis do not induce ISGs nor repeats
as observed in multiH1 KD, so we do not favor the model
in which the effects observed upon H1 depletion are medi-
ated only by DNA demethylation. Nonetheless, it was in-
teresting to address the global methylation state of DNA
in multiH1 KD cells. In this direction, we have evaluated
changes on global DNA methylation upon multiH1 KD
with a genome-wide CpG array that showed virtually no
differentially methylated CpGs after six days of doxycycline
treatment. Methylation of several ERV elements was also
analyzed by bisulphite PCR and changes were not found
(Supplementary Figure S9).
Due to all evidences reported here, we favor a model in
which histone H1 participates in the repression of genes
such as ISGs under basal conditions, and in the repression
of non-coding transcripts derived from repeats such as satel-
lites, transposons and endogenous retroviruses located in
heterochromatic regions which may cause, upon induction
in H1-depleted cells, activation of the IFN response (Fig-
ure 9). We have directly observed the increase of cytosolic
dsRNA within multi H1 KD cells, increased expression of
satellites and repeats, enhanced accumulation of RNAseq
reads from intergenic and intronic regions, and increased
chromatin accessibility of all these regions. It has been pre-
viously shown that tumor cells may contain retroelements-
derivedDNA in the cytosol forming structures includingR-
loops, whose levels are increased by genotoxic agents, which
activate the IFN response (70). We cannot disregard the
possibility that upon expression of repeat elements, R-loops
are formed andRNA:DNAor triple stranded fragments are
detected in the cytosol by sensors that induce the IFN path-
way (71). Overall, our data suggest that activation of ISGs
byH1KD ismediated by activating the IFN signaling path-
way, rather than by direct promoter relaxation due to H1
displacement.
ChIP analysis of ISG promoters upon multiH1 KD has
shown that active marks are not increased as it would be
expected for genes that are induced strongly. It has been
recently reported that developmental genes are activated
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in the absence of positive marks with the participation
of program-specific transcription factors (TFs), allowing
rapid activation and deactivation (64). ISGs may fall in this
category, where clearance of histoneH1, togetherwith bind-
ing of IRFs and NFkB to the promoters, may be sufficient
for activation. Forced depletion of H1 may be enough to
create a permissive chromatin environment to allow tran-
scription without the need of the contribution of active hi-
stone marks. Despite of this, H1 clearance may not be suf-
ficient without upstream induction of the IFN signaling
pathway that activate NFkB and IRFs to bind to the ISG
promoters. Thismay explainwhy the control genes analyzed
(and the large proportion of the transcriptome), that also
show H1.2 clearance, are not induced upon multiH1 KD,
favoring the model that IFN signaling is required. More-
over, our ChIP data and data extracted from the UCSC
browser shows that many ISGs present significant amounts
of H3K4me3 under basal conditions. This is a particularity
of genes that respond rapidly to stimulus, and may explain
why upon induction these genes do not show increased lev-
els of this mark, neither upon IFN-ß treatment.
A role of H1 in the regulation of ISGs has been sug-
gested before. The H1 chaperone SET/TAF-I has been sug-
gested to participate in theH1-mediated silencing of ISG15,
ISG54, ISG56 (IFIT1) and IFITM1 in HeLa cells (63). In
the absence of IFN, these genes were discretely up-regulated
(two-fold, in average) not only in TAF-I KD but also in
H1.2 KD cells. We have confirmed that TAF-I KD causes
modest up-regulation of some ISGs in T47D cells (data not
shown), but H1.2 KD does not in our hands, until com-
bined with another H1 (H1.4) variant KD. Then, induc-
tion fold-changes are much higher (Figure 3A), further sug-
gesting multiH1 KD induces ISGs not only due to its lo-
cal contribution to promoter chromatin structure, but also
inducing the IFN pathway upstream due to derepression
of DNA repeats. Whether this IFN signaling is caused by
heterochromatin instability and expression of repeats, orig-
inated in the altered H1 expression, DNA hypomethylation
or other chromatin alterations, are appealing possibilities
that need to be explored.
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